The stock of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) is a huge mover today! The stock increased 3.82% or $3.17 during the last trading session, reaching $86.05. About 335,564 shares traded or 25.94% up from the average. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) has risen 35.96% since August 30, 2016 and is uptrending. It has outperformed by 27.83% the S&P500.The move comes after 5 months positive chart setup for the $1.28B company. It was reported on Apr, 6 by Barchart.com. We have $92.93 PT which if reached, will make NASDAQ:EGRX worth $102.40 million more.
White Elm Capital Llc decreased Amtrust Finl Svcs Inc (AFSI) stake by 12.41% reported in 2016Q4 SEC filing. White Elm Capital Llc sold 262,500 shares as Amtrust Finl Svcs Inc (AFSI)’s stock rose 9.91%. The White Elm Capital Llc holds 1.85 million shares with $50.75 million value, down from 2.12M last quarter. Amtrust Finl Svcs Inc now has $3.03 billion valuation. The stock declined 0.05% or $0.01 reaching $19.24 per share. About 4.09 million shares traded or 19.94% up from the average. AmTrust Financial Services Inc (NASDAQ:AFSI) has declined 23.30% since August 30, 2016 and is downtrending. It has underperformed by 31.43% the S&P500.
Among 4 analysts covering Eagle Pharma (NASDAQ:EGRX), 3 have Buy rating, 1 Sell and 0 Hold. Therefore 75% are positive. Eagle Pharma had 11 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Tuesday, May 10 with “Outperform”. Mizuho downgraded it to “Neutral” rating and $78 target in Wednesday, November 16 report. Mizuho downgraded the stock to “Neutral” rating in Monday, June 20 report. William Blair maintained it with “Outperform” rating and $97 target in Wednesday, November 2 report. Mizuho downgraded Eagle Pharmaceuticals Inc (NASDAQ:EGRX) rating on Monday, January 9. Mizuho has “Underperform” rating and $64 target. The firm has “Buy” rating by Mizuho given on Wednesday, October 26. As per Friday, February 26, the company rating was maintained by Mizuho. The firm earned “Overweight” rating on Wednesday, July 29 by Piper Jaffray. RBC Capital Markets maintained the stock with “Outperform” rating in Thursday, November 3 report. The stock has “Buy” rating by Mizuho on Wednesday, December 9.
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company has market cap of $1.28 billion. The Firm focuses on developing and commercializing injectable products in the critical care and oncology areas. It has a 17.23 P/E ratio. The Company’s product portfolio includes products, including Argatroban; Ryanodex; docetaxel injection, non-alcohol formulation; and Bendeka.
Analysts await Eagle Pharmaceuticals Inc (NASDAQ:EGRX) to report earnings on May, 8. They expect $1.44 EPS, up 2,500.00% or $1.50 from last year’s $-0.06 per share. EGRX’s profit will be $21.42M for 14.94 P/E if the $1.44 EPS becomes a reality. After $3.52 actual EPS reported by Eagle Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts -59.09% negative EPS growth.
Analysts await AmTrust Financial Services Inc (NASDAQ:AFSI) to report earnings on May, 2. They expect $0.69 EPS, down 10.39% or $0.08 from last year’s $0.77 per share. AFSI’s profit will be $108.66M for 6.97 P/E if the $0.69 EPS becomes a reality. After $0.38 actual EPS reported by AmTrust Financial Services Inc for the previous quarter, Wall Street now forecasts 81.58% EPS growth.
Since October 17, 2016, it had 1 buy, and 21 sales for $998,569 activity. Shares for $247,604 were sold by Saxon Michael J. Shares for $4.44 million were bought by KARFUNKEL GEORGE on Friday, October 28. Shares for $135,266 were sold by Ungar Stephen on Monday, January 16. Shares for $88,064 were sold by DeCarlo Donald T. Another trade for 15,126 shares valued at $418,990 was made by Gulkowitz Abraham on Tuesday, December 20. Pipoly Ronald E Jr also sold $108,738 worth of AmTrust Financial Services Inc (NASDAQ:AFSI) on Tuesday, January 3.
Investors sentiment increased to 1.1 in Q4 2016. Its up 0.18, from 0.92 in 2016Q3. It is positive, as 36 investors sold AFSI shares while 68 reduced holdings. 38 funds opened positions while 76 raised stakes. 68.87 million shares or 1.72% less from 70.08 million shares in 2016Q3 were reported. United Capital Advisers Ltd Liability Com invested in 0.01% or 42,055 shares. Citadel accumulated 1.07 million shares. Breton Hill has 10,500 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% in AmTrust Financial Services Inc (NASDAQ:AFSI) or 3,068 shares. Delta Asset Mngmt Lc Tn has 80 shares for 0% of their portfolio. 563,777 were accumulated by Morgan Stanley. Hl Financial Ltd Co invested in 9,983 shares or 0.01% of the stock. Bbva Compass Bank Incorporated holds 11,269 shares or 0.02% of its portfolio. Principal Fincl, a Iowa-based fund reported 1.53 million shares. Pinnacle Assoc owns 35,181 shares or 0.02% of their US portfolio. State Common Retirement Fund reported 0.01% stake. Trexquant Invest Limited Partnership stated it has 0.07% in AmTrust Financial Services Inc (NASDAQ:AFSI). Swiss Fincl Bank owns 138,280 shares. 348,588 are owned by State Of Wisconsin Inv Board. Fuller And Thaler Asset Mgmt has 3,100 shares for 0% of their portfolio.
Among 6 analysts covering Amtrust Financial Services (NASDAQ:AFSI), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Amtrust Financial Services had 10 analyst reports since August 5, 2015 according to SRatingsIntel. Compass Point upgraded AmTrust Financial Services Inc (NASDAQ:AFSI) rating on Friday, November 13. Compass Point has “Buy” rating and $70 target. As per Wednesday, August 5, the company rating was downgraded by Compass Point. The stock of AmTrust Financial Services Inc (NASDAQ:AFSI) earned “Buy” rating by Compass Point on Thursday, February 11. The company was maintained on Friday, February 5 by Compass Point. The stock of AmTrust Financial Services Inc (NASDAQ:AFSI) has “Buy” rating given on Thursday, January 14 by Citigroup. The stock has “Buy” rating by William Blair on Thursday, September 3.
